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PDLIM2 is a cytoskeletal and nuclear PDZ-LIM domain protein that regulates the stability of Nuclear Factor kappa-
B (NFκB) and other transcription factors, and is required for polarized cell migration. PDLIM2 expression is
suppressed by methylation in different cancers, but is strongly expressed in invasive breast cancer cells that
have undergone an Epithelial Mesenchymal Transition (EMT). PDLIM2 is also expressed in non-transformed
breast myoepithelial MCF10A cells and here we asked whether it is important for maintaining the polarized,
epithelial phenotype of these cells. Suppression of PDLIM2 in MCF10A cells was sufficient to disrupt cell
polarization and acini formation with increased proliferation and reduced apoptosis in the luminal space
compared to control acini with hollow lumina. Spheroids with suppressed PDLIM2 exhibited increased
expression of cell-cell and cell-matrix adhesion proteins including beta 1 (β1) integrin. Interestingly, levels of the
Insulin-like growth factor 1 receptor (IGF-1 R) and Receptor of activated protein kinase C 1 (RACK1), which
scaffolds IGF-1R to β1 integrin, were also increased, indicating a transformed phenotype. Focal Adhesion Kinase
(FAK) and cofilin phosphorylation, and RhoA Guanosine Triphosphatase (GTPase) activity were all enhanced in
these spheroids compared to control acini. Importantly, inhibition of either FAK or Rho Kinase (ROCK) was
sufficient to rescue the polarity defect. We conclude that PDLIM2 expression is essential for feedback regulation
of the β1-integrin-RhoA signalling axis and integration of cellular microenvironment signals with gene expression
to control the polarity of breast epithelial acini structures. This is a mechanism by which PDLIM2 could mediate
tumour suppression in breast epithelium.
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Much evidence supports the concept that malignant transformation and
breast cancer progression are strongly linked not only with uncontrolled
growth but also with loss of polarized tissue architecture due to changes in
the cellular microenvironment. Many different studies have established
that signaling from the extracellular matrix (ECM) has a profound effect
on gene expression and cellular phenotype [1–4]. However, it is still not
understood how signals from the cellularmicroenvironment are integrated
with regulation of gene expression in normal epithelium compared with
transformed or invasive cancer cells. The transcription factor Nuclear
Factor kappa-B (NFκB) has recently been proposed to play an important
role in disrupting normal microenvironmental cues necessary for
maintaining tissue organization, with increased expression of many
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invasive phenotype [5,6]. We also recently proposed a role for the
PDLIM2 protein as a courier protein in integrating cytoskeletal signaling
with gene expression in the nucleus to control reversible epithelial-to-
mesenchymal transition (EMT) in breast and prostate cancer cells [7].
PDLIM2 (also known as Mystique or SLIM) is a cytoskeletal and
nuclear PDZ-LIM domain protein that regulates the stability of
several transcription factors including NFκB and signal transducer
and activator of transcription proteins (STATs) in hemopoietic and
epithelial cells [7–9]. It was first identified in corneal epithelial cells [10]
and in several cell types including fibroblasts transformed by
overexpression of the insulin-like growth factor 1 receptor (IGF-1R;
Mystique), epithelial cancer cells, [11–14], T lymphocytes (SLIM) [8,9],
and macrophages [9]. PDLIM2 is located on chromosome 8p21 [11],
which is frequently disrupted in various cancers [15], and its expression
has been associated with both tumorigenesis and tumor suppression. In
breast cancer cells, overexpression of PDLIM2 decreases anchorage-
independent growth and reduces tumor growth in vivo[11,13,14].
Moreover, PDLIM2 is repressed in both estrogen receptor–positive and
estrogen receptor–negative breast cancer cells [13], and vitamin D can
induce its re-expression and suppress motility and invasion in breast
cancer cell lines [9,16].However, PDLIM2 is highly expressed in cell lines
derived from metastatic cancer such as MDA-MB-231 breast cells and
androgen-independent prostate cells [7,11]. Suppression of PDLIM2
reverses the EMT phenotype of these cells and alters the activity of several
transcription factor families and the activity of the Constituitive
Photomorphogenic 9 Signalosome Complex (COP9 signalosome) in
the protein degradation pathway [7].
PDLIM2 expression is lower in MCF-7 (luminal type) than inMDA-
MB-231 (post EMT) breast cancer cells [7,11,17]. This is consistent with
data frompublicly available databases indicating that PDLIM2 expression
is associated with poor outcome in basal breast cancers [18]. Interestingly,
PDLIM2 is also highly expressed in MCF10A cells, which are polarized
non-transformed breast myoepithelial cells [9,11]. Because PDLIM2
expression may be repressed upon transformation and its expression may
reflect the differentiation status of breast cancer cells [7,11,13], we
hypothesised that in normal breast epithelium, PDLIM2 is required for
maintaining the polarized epithelial phenotype. To test this, we used the
classic model of three-dimensional (3D) acinar cultures of MCF10A cells
in Matrigel, whereby acini formation that simulates in vivo formation of
glandular epithelium requires distinct basolateral and apicolateral polarity
of the epithelial cells, as well as a coordinated balance of decreased
proliferation and increased apoptosis within the structures to permit
hollow lumen formation [19–22]. We found that PDLIM2 expression is
required for acini formation and that cells with suppressed PDLIM2 form
unpolarized spheroid structures. This was associatedwith dysregulation of
cues from the ECM, which is indicated by increased cell-cell and cell-
ECM signaling through β1-integrin, focal adhesion kinase (FAK), and
RhoA. Polarity could be restored by inhibition of either FAK or Rho
kinase (ROCK) activity. Our findings are consistent with an essential
function for PDLIM2 in integrating cellular microenvironment
signals with gene expression to control differentiation and polarity of
breast epithelium.
Materials and Methods
Cell Culture andGeneration of shPDLIM2-Expressing Cell Lines
MCF10A cells were cultured in a 50:50 mix of Dulbecco's
modified Eagle's medium/Ham's F12 medium (Sigma, Dublin,Ireland) supplemented with 5% horse serum, 1 μg/ml insulin, 20 ng/ml
epidermal growth factor (EGF), 100 ng/ml cholera toxin, 0.5 μg/ml
hydrocortisone, and 2 mM L-glutamine. MCF10A cell lines stably
expressing short hairpin RNA (shRNA) were generated by transfection
with pSUPER vectors encoding shRNA targeting PDLIM2 (shPDLIM2:
ACATAATCGTGGCCATCAA) or a control shRNA (shScramble:
TGACATGATAATACTCTCT), as described previously [7], using
Lipofectamine 2000, following the manufacturer's protocol. Cells
were cultured in the presence of 1 mg/ml G418 (Calbiochem, La
Jolla, CA) for 4 to 6 weeks, at which time individual clones were
screened for expression of PDLIM2 by Western blot analysis and
shScramble clones and shPDLIM2 clones with N60% suppression
were selectively expanded for experiments.
Reagents and Antibodies
Lipofectamine 2000 was from Invitrogen (Paisley, United Kingdom).
Antibodies: anti-PDLIM2 antibody was generated by Fusion Antibod-
ies (Belfast, Northern Ireland) using glutathione S-transferase (GST)–
tagged PDLIM2 (amino acids 79-352) as an immunogen. Anti–cleaved
caspase 3, phospho-cofilin (Ser3) and phospho-FAK (Tyr397) were
from Cell Signaling Technology (Beverly, MA). Anti-Receptor of
activated protein kinase C 1 (RACK1), Cyclin D1, E-cadherin, and β-
catenin were from BD Biosciences (Oxford, United Kingdom). Anti–
IGF-1R and FAK antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti–activated β1-integrin (CD29) was from
Millipore (Cork, Ireland). Anti-β1-integrin, (atypical) PKC zeta and
RhoA antibodies were from Abcam (Cambridge, United Kingdom).
Anti–α-tubulin and laminin were from Sigma-Aldrich (Dublin, Ireland).
Cy2- and Cy3-conjugated secondary antibodies were purchased from
Jackson ImmunoResearch Laboratories (Cambridgeshire, United
Kingdom). IRDye 680– and IRDye 800CW–conjugated antibodies
were from LI-COR Biosciences (Cambridge, United Kingdom). EGF
was purchased fromPeprotech (London,UnitedKingdom),Matrigel was
from Unitech (Dublin, Ireland), Y27632 was from ChemDea
(Ridgewood, NJ), and PF573228 was from Tocris Bioscience (R&D
Systems, Abingdon, United Kingdom). All other reagents were from
Sigma, unless otherwise noted.
Three-Dimensional Culture of MCF10A Cells
For MCF10A cell 3D acini formation, cells were grown in Matrigel
according to the protocol described by Debnath et al. [19]. Briefly,
shScramble and shPDLIM2-MCF10A cells were cultured as
described above in growth medium containing 1 mg/ml G418. A
single cell suspension (2000 cells per well) was plated in assay medium
(growth medium with 2% horse serum, without EGF or G418) onto
eight-well chamber slides coated with a layer of growth factor–
reduced Matrigel, and cells were overlaid with a 1:1 volume of assay
medium containing 40 ng/ml EGF and 2 mg/ml G418 and 4%
Matrigel. Cells were cultured for 12 days, with growth medium
replaced every 3 days. For inhibitor experiments, FAK inhibitor
(PF573228 (PF228); 50 nM), ROCK inhibitor (Y27632; 10 μM), or
0.1% DMSO vehicle control was added on the day of plating, and the
medium was changed every 3 days containing fresh inhibitor or
DMSO as appropriate.
Immunofluorescence Analysis and Confocal
Image Acquisition
Three-dimensional MCF10A acini were fixed and stained by
immunofluorescence cytology as described by Debnath et al. [19],
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primary antibodies for 1 to 2 hours, followed by Cy2- or Cy3-
conjugated secondary antibodies and nuclei visualized with Hoechst
dye as described previously [11]. Confocal sections were acquired
with a Nikon eC1 plus, TE2000E confocal laser scanning
microscope. Serial z-sections were obtained every 5 μM (usually
10-15 sections per field), and representative mid-section images were
analyzed using the EZ-C1 Gold version 3.90 build 869 software
(Aquilant Scientific, Dublin, Ireland) and processed for presentation
using Adobe Photoshop CS2 version 9.0.2 (Adobe Systems
Incorporated, San Jose, CA).
Cell Lysis and Western Blot Analysis
Total cellular protein extracts from 2D cell cultures were prepared
as described previously [9]. All protein samples for Western blot
analysis were separated by 10% sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis and transferred to a nitrocellulose
membrane. Following overnight incubation with primary antibody,
membranes were probed with IRDye 700– or IRDye 800–
conjugated secondary antibodies, and proteins were detected using
the Odyssey Image Scanner System (LI-COR Biosciences). The
approximate protein molecular weight in kilodaltons is indicated on
the left of each Western blot panel.
RhoA Guanosine Triphosphatase (GTPase) Activation
Pull-Down Assays
GST pull-down assays were performed as described elsewhere [23].
Briefly, cells were lysed in lysis buffer containing protease inhibitors.
Lysates were incubated at 4 °C for 1 hour with GST-Rhotekin coupled to
glutathione-sepharose beads (Amersham Biosciences, Buckinghamshire,
United Kingdom). Samples were resolved by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis andWestern blot analysis as described
above to determine levels of active RhoA.
Statistical Analysis
Data were analyzed for statistical significance using Student's t test to
compare samples where appropriate. A P value of b .05 was deemed
significant and graded P values are denoted in the presented data as
follows: *P b .05; **P b .005; ***P b .0005.
Results
PDLIM2 Suppression Disrupts MCF10A Acini Formation
To investigate whether PDLIM2 is required for polarized growth in
3D cultures, we stably suppressed PDLIM2 expression in MCF10A cells
using shRNA (shPDLIM2) and compared these to control cells
expressing scrambled shRNA (shScramble). PDLIM2 mRNA and
protein expression were suppressed by approximately 60% in MCF10A
cells stably expressing shPDLIM2 (Figure 1, A–C). Endogenous
PDLIM2 is expressed in both the cytoplasm and nuclei of MCF10A
cells (Figure W1, A and B), and shPDLIM2 cells showed a similar
reduction in cytoplasmic and nuclear PDLIM2 levels (Figure W1, B and
C). Cells were cultured in Matrigel for 12 days to allow spheroid
formation. Immunofluorescence and confocal analysis of 3D spheroids
demonstrated that shScramble MCF10A cells formed spheroids with
hollow lumina, whereas cells with PDLIM2 suppressed formed irregular-
shaped spheroids without distinct lumina (Figure 1D).
We next analyzed the size of spheroids formed by shPDLIM2
compared to shScramble cells and found significantly higher numbers of
larger spheroids (2-3mm2), with a concomitant decrease in spheroids of 1to 2 mm2 size, although numbers of the smallest acini (0.5-1 mm2) were
similar (Figure 1E). Importantly, the number of acini with distinct lumina
was reduced by more than 50% in the shPDLIM2 structures compared
with controls (Figure 1F). In addition, cyclin D1 expression was greatly
increased in the shPDLIM2 acini and activated caspase 3 activity was
reduced, indicating increased proliferation and reduced apoptosis within
the structures, compared with the shScramble cells (Figure 1G). Overall,
the data indicate that suppression of PDLIM2 disrupts the formation of
MCF10A acini.
Disrupted Polarity and Increased Cell-Cell and Cell-Matrix
Adhesion in MCF10A Acini with PDLIM2 Suppressed
We next investigated expression of markers of cell polarity and
adhesion in acinar structures with PDLIM2 suppressed. Laminin
and atypical protein kinase C both exhibited increased and diffuse
expression throughout the shPDLIM2 acini compared with a more
apico-basal staining pattern in control acini (Figure 2, A and B).
This was accompanied by increased E-cadherin and β-catenin
expression at cell-cell junctions of the shPDLIM2 acini compared
with control cells (Figure 2C). Together, these results indicate
disrupted cell polarity and increased cell-cell adherence in
shPDLIM2 3D spheroids. Similarly, fibronectin and β1-integrin
expression and activity were increased in the shPDLIM2 cells
(Figure 2D), as were the IGF-1R and the scaffolding protein
RACK1, which can integrate IGF-1R and integrin signaling
[24,25] (Figure 2E). All of these indicate increased interaction
with and signaling from the ECM and increased cooperative
signaling between the IGF-1R and β1-integrin signaling pathways
in cells with suppressed PDLIM2. Further, because increased IGF-
1R expression has previously been associated with MCF10A
transformation [26,27], and because cell polarity is severely
disrupted, the phenotype of shPDLIM2 MCF10A 3D structures
suggests that PDLIM2 can regulate breast epithelial
cell differentiation.
FAK and RhoA Activity Are Increased in MCF10A Acini with
Suppressed PDLIM2
To determine which signaling pathways downstream of β1-integrin
might account for the disrupted acinar polarity, we examined FAK and
RhoA GTPase activity. As expected from the increased β1-integrin
activation (Figure 2D), the activity of FAK indicated by phosphorylation
on Y397 was increased in shPDLIM2 cells (Figure 3A). Phosphorylation
of cofilin, which inhibits its normal activity in actin turnover, was also
increased throughout the shPDLIM2 structures (Figure 3A). This
increase in phosphorylation was confirmed by Western blot analysis in
shPDLIM2 MCF10A cells grown in 2D monolayer cultures (Figures 3,
B–D, and 4A).
Cofilin is phosphorylated downstream of ROCK, which is
activated by the RhoA GTPase in response to integrin/FAK
activation [4], and RhoA has a well-established function in
regulating morphology, cell polarity, and architecture of cells in
3D culture models [28], so we were interested to test whether
RhoA activity was altered by PDLIM2 suppression. RhoA activity
was assessed using GST-Rhotekin pull-down assays in shScram-
ble and shPDLIM2 cells grown in monolayer cultures. RhoA
GTPase activity was increased two-fold when PDLIM2 was
suppressed, demonstrating that the FAK/RhoA signaling pathway
is hyperactivated in MCF10A cells with suppressed PDLIM2
expression (Figure 3, E and F). Thus, the overall activity of the
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Figure 1. Loss of PDLIM2 expression disrupts acini formation in a 3D model. Clones of MCF10A cells stably expressing control shRNA
(shScramble) or shRNA targeting PDLIM2 (shPDLIM2) were examined for PDLIM2 protein expression. (A) A representativeWestern blot is
shown. (B) The graph represents densitometric quantification of PDLIM2 expression from four separate experiments (mean ± SEM). (C)
PDLIM2 mRNA expression was examined by quantitative polymerase chain reaction. The data represent mean of three separate
experiments ± SEM. (D) shScramble or shPDLIM2-MCF10A cells were cultured for 12 days inMatrigel, and 3D acini structures were fixed
and processed for immunofluorescence cytology and confocal imaging as described in Materials and Methods section. Representative
midplane images of confocal serial z-sections show PDLIM2 (red) and nuclear staining (Hoechst; blue) in MCF10A acini. (E) Quantification
of acinar size measured using the Fluoview software or (F) acini with distinct lumen, quantified from confocal images. Data shown are the
means ± SEM of at least 50 acini per cell type from each of three independent experiments in E and F (**P b .005; ***P b .0005). (G)
Proliferation (cyclin D1) and apoptosis (cleaved caspase 3) were analyzed in MCF10A acini by confocal microscopy. Nuclei are stained
blue. Images are representative of at least three separate experiments with similar results.
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sion of PDLIM2.
ROCK or FAK Inhibition Rescues Cells from PDLIM2
Suppression in Acinar Formation
We next tested whether inhibition of ROCK, the downstream
effector of RhoA activity that leads to phosphorylation of cofilin,
could rescue MCF10A cells from PDLIM2 suppression and allow
polarized acinar formation. We first demonstrated that low
concentrations of the ROCK inhibitor, Y27632, effectively reducedthe basal levels of cofilin phosphorylation observed in shScramble
MCF10A cells and reversed the increase in cofilin phosphorylation
observed in shPDLIM2 cells (Figures 4, A and B, and W2, A and
B). Cells were then cultured in Matrigel with Y27632 or DMSO as
vehicle control. After 12 days, both shScramble and shPDLIM2 3D
structures had greatly reduced cofilin phosphorylation (Figures 4C
and W2B), and it was clear that shPDLIM2 cells could now form
hollow lumina with the outer cells exhibiting reduced β1-integrin
and β-catenin expression compared to vehicle controls (Figure 4C).
Quantification of the profiles of acinar size showed an approximately
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Figure 2. Suppression of PDLIM2 affects polarization and enhances cell-cell and cell-matrix adhesion in a 3D model of MCF10A acini
formation. Twelve-day-old cultures of shScramble and shPDLIM2 MCF10A acinar structures were fixed and processed for confocal
microscopy analysis. (A) Basal polarity was assessed by staining for laminin (green) and apical polarity by atypical protein kinase C (red)
localization in shScramble and shPDLIM2 MCF10A structures. Midplane confocal Images are shown with x:y cross-sections on the
bottom and right panels of each image. (C) E-cadherin and β-catenin expression was examined in MCF10A acini. (D) Fibronectin and β1-
integrin expression was examined in shScramble and shPDLIM2 MCF10A acini by confocal microscopy. (E) ShScramble and shPDLIM2
MCF10A 3D structures were examined for IGF-1R (red) and RACK1 (green) expression. Representative confocal midplane sections of 5
μm serial z-sections are presented, nuclei are blue, and data are representative of at least three independent experiments with similar
results (A-E).
426 Essential Function for PDLIM2 in Cell Polarization Deevi et al. Neoplasia Vol. 16, No. 5, 2014two-fold decrease in larger sized acini compared with vehicle control
shPDLIM2 cells (Figure 4D). There was also a two-fold increase in
numbers of acini exhibiting hollow lumina in shPDLIM2 cells
treated with the ROCK inhibitor (Figure 4E). These data indicatethat PDLIM2 is required to regulate RhoA-dependent polarization
and lumen formation in breast epithelial cell acini.
Next, we investigated whether inhibition of FAK activity,
upstream of ROCK, could also rescue the defect in acini formation
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Figure 3. FAK and RhoA activity are increased in MCF10A cells with suppressed PDLIM2 expression. (A) ShScramble and shPDLIM2MCF10A
cells were grown in 3D culture for 12 days and fixed and stained for β1-integrin and phosphorylation of FAK and cofilin. Representative confocal
midplane z-sections are presented. (B) Western blot analysis of P-FAK expression in shScramble and shPDLIM2 MCF10A cells. Densitometric
quantification of phosphorylation of FAK (C) and cofilin (D) in shPDLIM2 comparedwith shScrambleMCF10A cells using the Odyssey software.
The graph represents mean ± SEM of three independent experiments. (E) RhoA activity was assessed using GST-Rhotekin pull-down assays
from lysates of shScramble and shPDLIM2 MCF10A cells. Total lysates were probed for RhoA expression as loading control. (F) RhoA activity
was quantified using the Odyssey software from three independent GST pull-down assays in shScramble and shPDLIM2 MCF10A cells. The
graph represents mean ± SEM; **P b .005; ***P b .0005.
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suppressed FAK phosphorylation in MCF10A cells (Figures 5, A
and B, and W2, C and D). RhoA activity was also significantly
decreased in shPDLIM2 cells exposed to the FAK inhibitor
(Figure 5, C and D). ShPDLIM2 cells cultured in Matrigel in the
presence of FAK inhibitor displayed decreased FAK and cofilin
phosphorylation and levels of β1-integrin and β-catenin were also
slightly reduced (Figure 5E). Similar to observations with the
ROCK inhibitor, shPDLIM2 cells cultured with the FAK inhibitorformed smaller acini than cells cultured with control vehicle
(Figure 5F), and the overall number of shPDLIM2 3D structures
exhibiting distinct hollow lumina was greatly increased
(Figure 5G).
Taken together, these results demonstrate that inhibition of
either RhoA or FAK is sufficient to rescue cells from the effects
of suppression of PDLIM2 and re-enable luminal formation
within 3D acini. This suggests that PDLIM2 suppression
promotes β1-integrin–induced FAK-mediated activation of the
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Figure 4. Inhibition of ROCK can rescue the morphologic and
polarization defects of MCF10A acini due to loss of PDLIM2
expression. (A) Inhibition of ROCK activity following treatment with
the ROCK inhibitor (Y27; 10 μM, 24 hours) was validated by
assessment of cofilin phosphorylation by Western blot. Samples
were also probed for PDLIM2 expression and tubulin as loading
controls. (B) Graph showing fold change of P-cofilin expression
following ROCK inhibition in shPDLIM2 MCF10A, quantified by
densitometry; data are means ± SEM from three separate
experiments. (C) ShPDLIM2 MCF10A cells were cultured in 3D
Matrigel assay for 12 days in the presence of ROCK inhibitor
(Y27; 10 μM) or DMSO vehicle (control). Cell structures were
fixed and processed for confocal microscopy analysis. Repre-
sentative confocal midplane sections are shown, and nuclei are
blue. (D) Quantification of size of shPDLIM2 MCF10A acinar
structures measured using the Fluoview software or (E) acini with
distinct lumina, quantified from confocal images. Data are
presented as means ± SEM of at least 50 acini per cell culture
condition from three independent experiments in D and E; **P b .005;
***P b .0005.
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regulating this β1-integrin signaling pathway in breast epithelial
cell polarization and 3D acinar formation. This pathway is
summarized in Figure 6.Discussion
Here, we show that PDLIM2 is required for generation of polarized
MCF10A acini in 3D where it mediates feedback regulation of the
β1-integrin signaling pathway. PDLIM2 expression is also required to
maintain an EMT phenotype in metastatic cancer cells where it
regulates transcription of a large set of genes associated with the EMT
phenotype [7]. Moreover, PDLIM2 expression can be induced by
vitamin D in breast cancer cells and this enhances adhesion signaling
[9,16]. Thus, PDLIM2 acts to integrate signals from the ECM with
gene expression that is critical in determining breast epithelial cell
phenotype. PDLIM2 expression levels and subcellular location may,
in turn, be crucial in determining malignant transformation potential.
Although PDLIM2 has been characterized as a nuclear transcrip-
tion factor regulator in lymphocytes and to mediate cytoskeletal and
nuclear functions and potentially tumor suppression in epithelial
cells, an essential function in normal epithelial cells [9–12] has not
been established. However, on the basis of the observations from
macrophages and cancer cell lines, it was rational to propose an
important role in reversible differentiation, whereby PDLIM2
expression could be suppressed to facilitate transformation or induced
to facilitate EMT in epithelial cancer cells. The 3D culture model of
MCF10A breast epithelial cell acini formation is an ideal system to
test this concept because the process requires regulated remodeling of
cells within the ECM, choreographed polarization of epithelial cells,
and a balance between increased apoptosis and decreased proliferation
[19–22]. The results were dramatically clear. Cells with suppressed
PDLIM2 were deficient in apico-basal polarization and formed
proliferating spheroid structures with decreased apoptosis all
indicating a transformed phenotype [27,29]. Altered expression of
proteins that mediate cell-cell and cell-ECM adhesions as previously
described in breast epithelial transformation (reviewed in [2]) also
supported the conclusion that MCF10A cells with suppressed
PDLIM2 become transformed.
Increased β1-integrin expression and activation was associated with
hyperactivation of the downstream FAK-RhoA-ROCK signaling
pathway in MCF10A cells with suppressed PDLIM2. Rho/ROCK
regulation by FAK is necessary for mammary branching morpho-
genesis [30], and β1-integrin–dependent cell adhesion to the ECM is
known to activate RhoA that is required for cell contractility [30,31],
a major function of myoepithelial cells within the mammary duct [2].
The importance of β1-integrin signaling with RhoA in cell
morphology and tissue architecture has been demonstrated in other
cell types. For example, in endothelial cells, increased β1-integrin
activation causes increased RhoA-dependent endothelial contractility
resulting in irregular ECM remodeling [31]. β1-Integrin is important
for cell proliferation in 3D cultures of prostate cancer cells [32] and
controls morphology, adhesion, and invasion of breast cancer cells in
both 2D and 3D models, through regulation of the FAK-RhoA
pathway [4]. Inhibition of either β1-integrin or FAK signaling can
reduce growth of chemoresistant breast cancer cells in 3D models
[33]. Importantly, in this study, inhibition of the FAK-RhoA-ROCK
pathway at either FAK or ROCK was sufficient to restore the defects
in acinar formation of MCF10A cells with suppressed PDLIM2,
including restoration of β1-integrin expression to levels similar to
control cells. This indicates that control of this pathway by PDLIM2
is at the level of β1-integrin expression and activation and that
PDLIM2 is required for a regulatory feedback loop from β1-integrin
to FAK-RhoA-ROCK activation in breast epithelial cell acinar
formation (summarized in Figure 6).
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in the shPDLIM2 3D structures. This is not entirely surprising as it
was previously shown that β1-integrin expression regulates IGF-1R
levels and activation in prostate cancer cells [32,34]. We and others
have also described how, upon ECM protein–β1-integrin ligation,
RACK1 is recruited to the IGF-1R, forming a signaling complex with
β1-integrin that provides a platform for recruitment and activation of
several key signaling molecules including FAK [24,25,35–39].
Increased expression and activation of IGF-1R in MCF10A cells
has also been shown to induce similar hyperproliferative disorganized
3D structures [26,27], and conversely, suppression of IGF-1R causes
growth inhibition and polarization of MCF-7 cells in a 3D model
[40]. Thus, increased activated β1-integrin in cells with suppressed
PDLIM2 would mediate the increased cell proliferation and FAK-
RhoA-ROCK activation by recruiting IGF-1R and RACK1. This
may also be a mechanism by which PDLIM2 suppression couldP-FAK P-cofilin
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FAK125facilitate acquisition of the invasive EMT phenotype associated with
basal-like breast cancers.
How PDLIM2 regulates β1-integrin expression at the mRNA or
protein level is not yet entirely clear. NFκB is an obvious candidate
for transcriptional regulation and is already implicated as a
PDLIM2 target. It is also involved in feedback from β1-integrin
signaling in 3D breast cancer models, associated with disorganized
invasive structures [5,6]. PDLIM2 can regulate NFκB-p65
expression/stability in lymphocytes and macrophages [9,41], but
we found no evidence of altered p65 levels in MCF10A or other
epithelial cells [7]. Moreover, we recently demonstrated that
PDLIM2 regulates activity of the COP9 signalosome (CSN),
resulting in differential expression of several transcription factor
families, and altered expression of many EMT-associated proteins
[7]. We therefore propose that the key to PDLIM2 actions is in
maintaining cellular polarity by its ability to shuttle from the
cytoskeleton to the nucleus to facilitate integration of cytoskeletal
signaling with gene expression. It is likely that decreased PDLIM2
at both the cytoskeleton and the nucleus causes cumulative effects
on cell matrix interactions, transcription factor activity, and gene
expression. Loss of feedback signaling to regulate integrin
expression levels in MCF10A cells is a major component of
these effects.
Conclusion
In conclusion, we propose that PDLIM2 has an essential function in
maintaining breast epithelial cell polarity at the level of feedback
signaling through the β1-integrin–FAK–RhoA axis. Furthermore, by
integrating signals from the actin cytoskeleton with gene expression
to determine cell phenotype, PDLIM2 has potential to both suppress
breast epithelial transformation and also to facilitate maintenance
of an EMT phenotype. It will now be important to determine
how PDLIM2 expression and subcellular location is regulated in
breast cancer.Figure 5. Disruption of acini formation and associated increased
RhoA activation of MCF10A with suppressed PDLIM2 expression
are dependent on β1-integrin regulation of FAK/RhoA pathway. (A)
Inhibition of FAK activity following treatment with the FAK inhibitor
(PF228; 50 nM, 24 hours) was validated by assessment of
phosphorylation of FAK by Western blot analysis. Total FAK levels,
PDLIM2 expression, and tubulin expression are also presented as
controls. (B) Graph showing fold change of P-FAK in shPDLIM2
MCF10A, quantified by densitometry of P-FAK expression from
three independent experiments, presented as mean ± SEM.
(C) shPDLIM2 MCF10A cells were treated with the FAK inhibitor
(PF228; 50 nM) and RhoA activity assessed using a GST-Rhotekin
pull-down assay. Total lysates were probed for RhoA expression as
loading control. (D) RhoA activity was quantified using the Odyssey
software from three independent GST pull-down assays in
shPDLIM2 MCF10A cells treated with the FAK inhibitor. The
graph represents mean ± SEM. (E) shPDLIM2 MCF10A cells were
cultured in 3D Matrigel assay for 12 days in the presence or
absence of FAK inhibitor (PF228; 50 nM) or DMSO vehicle (control).
Cell structures were fixed and processed for confocal analysis of P-
FAK and P-cofilin expression. Representative confocal midplane
sections; nuclei are blue. (F) Quantification of shPDLIM2 MCF10A
acinar size measured using the Fluoview software or (G) shPDLIM2
MCF10A acini with distinct lumina, quantified from confocal
images. Data shown are means ± SEM of at least 50 acini per
cell culture condition from each of three independent experiments
in F and G; **P b .005; ***P b .0005.
Figure 6. PDLIM2 has an essential function in maintaining breast epithelial cell polarity at the level of feedback signaling through the β1-
integrin–FAK–RhoA axis. Suppression of PDLIM2 expression prevents negative feedback control of FAK-ROCK-RhoA signaling
downstream of β1-integrin resulting in hyperactivation of the pathway causing dysregulation of polarization, proliferation/apoptosis, cell-
cell and cell-matrix adhesion, and loss of normal phenotype of breast epithelial cells.
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